GlassScriptPhysician profile
Vicki Larue
NPI 1932158516
$1,438.82
in general payments reported to CMS, 2019-2025
16 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $198 · 2022: $294 · 2023: $576 · 2024: $96.66 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695 · Education: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.74 |
| Education | $251.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $543.31 | 2021-2025 | Veozah |
| Mayne Pharma Commercial LLC | $249.09 | 2022-2023 | |
| Abbvie INC. | $154.39 | 2021-2022 | |
| Exact Sciences Corporation | $119.70 | 2025 | The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $119.21 | 2023 | Fasenra |
| Ultragenyx Pharmaceutical INC. | $39.43 | 2022 | |
| Organon LLC | $39.07 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $37.41 | 2021 | |
| Merck Sharp & Dohme LLC | $36.28 | 2021-2024 | Vaxneuvance, Gardasil 9, Gardasil |
| Novo Nordisk INC | $17.80 | 2025 | |
| Evofem Biosciences, INC. | $17.36 | 2021 | |
| Millicent US INC | $15.96 | 2025 | Femlyv |
| Amgen INC. | $12.81 | 2021 | |
| Lilly USA, LLC | $12.80 | 2021 | |
| Hologic Sales and Service, LLC | $12.50 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $11.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicki Larue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.